Buscar
Mostrando ítems 1-10 de 346
Design of novel antituberculosis compounds using graph-theoretical and substructural approaches
(SPRINGER, 2009)
The increasing resistance of Mycobacterium tuberculosis to the existing drugs has alarmed the worldwide scientific community. In an attempt to overcome this problem, two models for the design and prediction of new ...
In vitro studies on the release of isoniazid incorporated in poly(epsilon-caprolactone)
(Esift SrlFlorenceItália, 2006)
Efectos adversos de consecuencia fatal por tratamiento con fármacos antituberculosos
(Universidad Peruana Cayetano Heredia. Facultad de Medicina "Alberto Hurtado", 2002)
Systematic review on the proteomic profile of Mycobacterium tuberculosis exposed to drugs
(Wiley-Blackwell, 2017-12-01)
The authors present an overview about proteomics studies in Mycobacterium tuberculosis exposed to some anti-tuberculosis drugs and new candidates, using two-dimensional gel electrophoresis and mass spectrometry. To date, ...
Potential of Casiopeínas® Copper Complexes and Antituberculosis Drug Combination against Mycobacterium tuberculosis
(2016-02-25)
New compounds with antituberculosis activity and their combination with classic drugs have been evaluated to determine possible interactions and antagonism. The aim of this study was to evaluate the in vitro activity of ...
Adverse reactions to antituberculosis drugs in Manguinhos, Rio de Janeiro, Brazil
(Faculdade de Medicina/USP, 2019)
Structure-activity relationship analysis of 4 '-bromo-[1,1 '-biphenyl]-4-yl 4-X-phenyl methanone derivatives and activity against Mycobacterium tuberculosis
(Ecv-editio Cantor Verlag Medizin NaturwissenschaftenAulendorfAlemanha, 1999)
Increase of leishmanicidal and tubercular activities using steroids linked to aminoquinoline
(2012)
Background: Aminoquinoline/steroid conjugates were synthesized based on the fact that steroid transporters have been shown to accept and carry a variety of drugs. So, in continuing our research of antileishmanial and ...
Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination
(Elsevier B.V., 2016-12-01)
We report the in vitro drugs interaction by the resazurin drugs combination micro-titer assay (REDCA) of amoxicillin (AMO)/clavulanate (CLAV) with isoniazid (INH), ethambutol (EMB), and rifampicin (RIF) against susceptible ...